Literature DB >> 3550371

In vitro evidence that bone formation may be coupled to resorption by release of mitogen(s) from resorbing bone.

J R Farley, N Tarbaux, L A Murphy, T Masuda, D J Baylink.   

Abstract

Bone-derived proteins have been shown to stimulate the proliferation of bone-forming cells and to increase the rate of embryonic bone formation in vitro. The current studies were intended to determine the tissue distribution of bone cell-active mitogen(s) in the embryonic chick, to determine the cellular origin and the target cell specificity of the bone cell-active mitogen(s) in embryonic chick bone, to determine whether the release of mitogenic activity from embryonic chick tibiae was proportional to bone resorption, and to compare mitogenic activities prepared from different skeletal sources, with respect to Mr, chemical stability, and mitogen activity kinetics. A bone cell-active mitogen(s) was identified in extracts of bone and cartilage but not in extracts of muscle, liver, intestine, or brain. (Mitogenic activity was determined as increased incorporation of 3[H]-thymidine into DNA in serum-free, calvarial cell cultures.) Together, the following three observations indicate an osteoblastic origin for the bone cell-active mitogen(s) in chick bone. First, the mitogen content of embryonic chick tibiae increased 4.5-fold, during eight days of serum-free in vitro growth (P less than .005). Second, conditioned medium (CM) from serum-free monolayer cultures of calvarial cells contained bone cell-active mitogen(s), but CM from parallel cultures of skin, liver, and intestinal cells did not. And, finally, the amount of bone cell-active mitogen(s) in calvarial cell CM was correlated with the amount of alkaline phosphatase (ALP) activity per cell, ie, an index of osteoblastic differentiation (r = .92, P less than .005).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3550371     DOI: 10.1016/0026-0495(87)90200-9

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  12 in total

1.  [Renal osteopathy--an extra-orthopedic zone?].

Authors:  C Wittig
Journal:  Orthopade       Date:  2004-03       Impact factor: 1.087

2.  Lack of in vitro evidence for storage of 1,25-dihydroxycholecalciferol (1,25(OH)2D3) and 1,25(OH)2D3 binding protein in skeletal matrix.

Authors:  S Boonen; J Aerssens; I Jans; E Van Herck; I Vandewal; J Peeters; R Van den Eynde; J Dequeker; R Bouillon
Journal:  Calcif Tissue Int       Date:  1996-12       Impact factor: 4.333

3.  Prevention of ovariectomy osteopenia in rats after vaginal administration of Hyaff 11 microspheres containing salmon calcitonin.

Authors:  E Bonucci; P Ballanti; P A Ramires; J L Richardson; L M Benedetti
Journal:  Calcif Tissue Int       Date:  1995-04       Impact factor: 4.333

4.  Calcitonin (but not calcitonin gene-related peptide) increases mouse bone cell proliferation in a dose-dependent manner, and increases mouse bone formation, alone and in combination with fluoride.

Authors:  J R Farley; S L Hall; N M Tarbaux
Journal:  Calcif Tissue Int       Date:  1989-10       Impact factor: 4.333

5.  Hepatocyte growth factor is a coupling factor for osteoclasts and osteoblasts in vitro.

Authors:  M Grano; F Galimi; G Zambonin; S Colucci; E Cottone; A Z Zallone; P M Comoglio
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

6.  An age-related decrease in the concentration of insulin-like growth factor binding protein-5 in human cortical bone.

Authors:  V Nicolas; S Mohan; Y Honda; A Prewett; R D Finkelman; D J Baylink; J R Farley
Journal:  Calcif Tissue Int       Date:  1995-09       Impact factor: 4.333

7.  Ovariectomy selectively reduces the concentration of transforming growth factor beta in rat bone: implications for estrogen deficiency-associated bone loss.

Authors:  R D Finkelman; N H Bell; D D Strong; L M Demers; D J Baylink
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

8.  In vitro evidence that local and systemic skeletal effectors can regulate 3[H]-thymidine incorporation in chick calvarial cell cultures and modulate the stimulatory actions(s) of embryonic chick bone extract.

Authors:  J R Farley; N M Tarbaux; J P Vermeiden; D J Baylink
Journal:  Calcif Tissue Int       Date:  1988-01       Impact factor: 4.333

9.  Vanadium derivatives act as growth factor--mimetic compounds upon differentiation and proliferation of osteoblast-like UMR106 cells.

Authors:  A M Cortizo; S B Etcheverry
Journal:  Mol Cell Biochem       Date:  1995-04-26       Impact factor: 3.396

10.  Cancellous bone properties and matrix content of TGF-beta2 and IGF-I in human tibia: a pilot study.

Authors:  Yener N Yeni; X Neil Dong; Bingbing Zhang; Gary J Gibson; David P Fyhrie
Journal:  Clin Orthop Relat Res       Date:  2009-05-27       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.